Medicine and Dentistry
Chronic Thromboembolic Pulmonary Hypertension
100%
Pulmonary Hypertension
70%
Venous Thromboembolism
37%
Splenectomy
23%
Myeloproliferative Disorder
23%
Acute Pulmonary Embolism
23%
Anticoagulant Therapy
22%
Hemodynamic
20%
Bleeding
18%
Atrial Septal Defect
18%
Kyphoscoliosis
18%
Antiphospholipid Syndrome
18%
Thrombocytopenia
18%
Anemia
18%
Idiopathic Thrombocytopenic Purpura
18%
Vaccination Coverage
18%
Primary Immunodeficiency
18%
Vaccine Hesitancy
18%
Dasatinib
18%
COVID-19 Vaccination
18%
Angioplasty
18%
Lung Vascular Resistance
18%
Major Bleeding
15%
Cardiac Catheterization
15%
Brain Natriuretic Peptide
11%
Platelet
11%
Lung Artery Pressure
10%
Pulmonary Embolism
10%
Prevalence
10%
Antiphospholipid Antibody
9%
Hazard Ratio
8%
Dyspnea
7%
Cardiovascular System
7%
Systolic Blood Pressure
6%
Oxygen Therapy
6%
Ambrisentan
6%
Echocardiography
6%
Heart Left Ventricle Ejection Fraction
6%
Pulmonary Artery Occlusion Pressure
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Thromboembolic Pulmonary Hypertension
65%
Pulmonary Hypertension
45%
Venous Thromboembolism
37%
Anticoagulant Agent
18%
Kyphoscoliosis
18%
Bleeding
18%
Anemia
18%
Brain Natriuretic Peptide
8%
Prevalence
7%
Survival Rate
7%
Obstruction
7%
Ambrisentan
6%